{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:22Z","timestamp":1776329842095,"version":"3.50.1"},"reference-count":15,"publisher":"Baskent University","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.6002\/ect.2021.0020","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T01:11:01Z","timestamp":1627261861000},"page":"990-993","source":"Crossref","is-referenced-by-count":3,"title":["Thrombotic Microangiopathy, Antibody-Mediated Rejection, and Posterior Reversible Leukoencephalopathy Syndrome in a Liver Transplant Recipient: Interplay Between COVID-19 and Its Treatment Modalities"],"prefix":"10.6002","volume":"19","author":[{"given":"Simin","family":"Dashti-Khavidaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Moghadamnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Jafarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolhamid","family":"Chavoshi-Khamneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alimohammad","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Ahmadinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Ghiasvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davod","family":"Tasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Nasiri-Toosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant. 2020;20(7):1800-1808. doi:10.1111\/ajt.15941","DOI":"10.1111\/ajt.15941"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Kremer Hovinga JA, Coppo P, L\u00e4mmle B, Moake JL, Miyata T, Vanhoorelbeke K. Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers. 2017;3:17020. doi:10.1038\/nrdp.2017.20","DOI":"10.1038\/nrdp.2017.20"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Shindoh J, Sugawara Y, Akamatsu N, et al. Thrombotic microangiopathy after living-donor liver transplantation. Am J Transplant. 2012;12(3):728-736. doi:10.1111\/j.1600-6143.2011.03841.x","DOI":"10.1111\/j.1600-6143.2011.03841.x"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol. 2008;29(5):924-930. doi:10.3174\/ajnr.A0960","DOI":"10.3174\/ajnr.A0960"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Burrus TM, Wijdicks EF, Rabinstein AA. Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura. Neurology. 2009;73(1):66-70. doi:10.1212\/WNL.0b013e3181aaea1b","DOI":"10.1212\/WNL.0b013e3181aaea1b"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Albiol N, Awol R, Martino R. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19. Ann Hematol. 2020;99(7):1673-1674. doi:10.1007\/s00277-020-04097-0","DOI":"10.1007\/s00277-020-04097-0"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Kundra A, Wang JC. Interferon induced thrombotic microangiopathy (TMA): analysis and concise review. Crit Rev Oncol Hematol. 2017;112:103-112. doi:10.1016\/j.critrevonc.2017.02.011","DOI":"10.1016\/j.critrevonc.2017.02.011"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Lee M. Antibody-mediated rejection after liver transplant. Gastroenterol Clin North Am. 2017;46(2):297-309. doi:10.1016\/j.gtc.2017.01.005","DOI":"10.1016\/j.gtc.2017.01.005"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Walter T, Dumortier J, Guillaud O, et al. Rejection under alpha interferon therapy in liver transplant recipients. Am J Transplant. 2007;7(1):177-184. doi:10.1111\/j.1600-6143.2006.01590.x","DOI":"10.1111\/j.1600-6143.2006.01590.x"},{"key":"ref9","unstructured":"10. Rhodes J, Jones DH, Bleehen NM. Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo. Clin Exp Immunol. 1983;53(3):739-743"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Davoudi-Monfared E, Rahmani H, Khalili H, et al. A randomized clinical trial of the efficacy and safety of interferon beta-1a in treatment of severe COVID-19. Antimicrob Agents Chemother. 2020;64(9). doi:10.1128\/AAC.01061-20","DOI":"10.1128\/AAC.01061-20"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Dashti-Khavidaki S, Mohammadi K, Khalili H, Abdollahi A. Pharmacotherapeutic considerations in solid organ transplant patients with COVID-19. Expert Opin Pharmacother. 2020;21(15):1813-1819. doi:10.1080\/14656566.2020.1790526","DOI":"10.1080\/14656566.2020.1790526"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010;50(5):e30-e33. doi:10.1086\/650488","DOI":"10.1086\/650488"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Anand P, Lau KHV, Chung DY, et al. Posterior reversible encephalopathy syndrome in patients with coronavirus disease 2019: two cases and a review of the literature. J Stroke Cerebrovasc Dis. 2020;29(11):105212. doi:10.1016\/j.jstrokecerebrovasdis.2020.105212","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105212"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Song T, Rao Z, Tan Q, et al. Calcineurin inhibitors associated posterior reversible encephalopathy syndrome in solid organ transplantation: report of 2 cases and literature review. Medicine (Baltimore). 2016;95(14):e3173. doi:10.1097\/MD.0000000000003173","DOI":"10.1097\/MD.0000000000003173"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T04:30:15Z","timestamp":1632285015000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2021\/19\/9\/0\/990\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0020","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}